rs766760741
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_015884.4(MBTPS2):c.529A>C(p.Ile177Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000662 in 1,057,310 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015884.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBTPS2 | ENST00000379484.10 | c.529A>C | p.Ile177Leu | missense_variant | Exon 4 of 11 | 1 | NM_015884.4 | ENSP00000368798.5 | ||
MBTPS2 | ENST00000365779.2 | c.529A>C | p.Ile177Leu | missense_variant | Exon 4 of 7 | 1 | ENSP00000368796.1 | |||
MBTPS2 | ENST00000465888.1 | n.628A>C | non_coding_transcript_exon_variant | Exon 4 of 6 | 2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183354Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67820
GnomAD4 exome AF: 0.00000662 AC: 7AN: 1057310Hom.: 0 Cov.: 26 AF XY: 0.00000306 AC XY: 1AN XY: 326538
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
IFAP syndrome 1, with or without BRESHECK syndrome Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 177 of the MBTPS2 protein (p.Ile177Leu). This variant is present in population databases (rs766760741, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with MBTPS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 522925). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MBTPS2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at